Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Subcutaneous Elafin in Healthy Subjects
NCT03522935Phase 1Completed
- Start
- Mar 2019
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of tiprelestat in pulmonary arterial hypertension (PAH). Started Mar 2019; status: completed.
02
Drugs
tiprelestat
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03522935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03522935.